 |
|
Recent Progress of Genome Study for Anaplastic Thyroid Cancer
Jieun Lee, Jung-Ah Hwang, Eun Kyung Lee
Genomics Inform. 2013;11(2):68-75. Published online 2013 Jun 30 DOI: https://doi.org/10.5808/GI.2013.11.2.68
|
|
Citations to this article as recorded by
 Results of treatment of patients with poorly differentiated carcinoma of the thyroid gland
P. A. Isaev, V. V. Polkin, N. V. Severskaya, A. A. Ilyin, A. K. Plugar, S. A. Ivanov, A. D. Kaprin
Head and Neck Tumors (HNT).2023; 12(4): 17. CrossRef Follicular Thyroid Adenoma and Follicular Thyroid Carcinoma—A Common or Distinct Background? Loss of Heterozygosity in Comprehensive Microarray Study
Martyna Borowczyk, Paula Dobosz, Ewelina Szczepanek-Parulska, Bartłomiej Budny, Szymon Dębicki, Dorota Filipowicz, Elżbieta Wrotkowska, Michalina Oszywa, Frederik A. Verburg, Małgorzata Janicka-Jedyńska, Katarzyna Ziemnicka, Marek Ruchała
Cancers.2023; 15(3): 638. CrossRef Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin
Poupak Fallahi, Silvia Martina Ferrari, Giusy Elia, Francesca Ragusa, Armando Patrizio, Sabrina Rosaria Paparo, Gianni Marone, Maria Rosaria Galdiero, Giovanni Guglielmi, Rudy Foddis, Alfonso Cristaudo, Alessandro Antonelli
Seminars in Cancer Biology.2022; 79: 203. CrossRef Molecular targets of tyrosine kinase inhibitors in thyroid cancer
Poupak Fallahi, Silvia Martina Ferrari, Maria Rosaria Galdiero, Gilda Varricchi, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Salvatore Benvenga, Alessandro Antonelli
Seminars in Cancer Biology.2022; 79: 180. CrossRef CDH3 is associated with poor prognosis by promoting the malignancy and chemoresistance in oral squamous cell carcinoma
Tong Wu, ZhiChao Xiao, YiXuan Li, Zan Jiao, Xiang Liang, YongQ. Zhang, HuoW. Liu, Ankui Yang
Asian Journal of Surgery.2022; 45(12): 2651. CrossRef Looking at Thyroid Cancer from the Tumor-Suppressor Genes Point of View
Sadegh Rajabi, Catherine Alix-Panabières, Arshia Sharbatdar Alaei, Raziyeh Abooshahab, Heewa Shakib, Mohammad Reza Ashrafi
Cancers.2022; 14(10): 2461. CrossRef Synergistic effect of metformin and vemurufenib (PLX4032) as a molecular targeted therapy in anaplastic thyroid cancer: an in vitro study
Latha Durai, Soundharya Ravindran, Krishnamurthy Arvind, Devarajan Karunagaran, Ramshankar Vijayalakshmi
Molecular Biology Reports.2021; 48(11): 7443. CrossRef APOPTOSIS ROLE IN FORMING RADIOIODINE RESISTANCE IN DIFFERENTIATED THYROID CANCER
K.A. GARIPOV, Z.A. AFANASIEVA, A.D. GAFIULLINA
AVICENNA BULLETIN.2020; : 301. CrossRef Recent advances in precision medicine for the treatment of anaplastic thyroid cancer
Silvia Martina Ferrari, Poupak Fallahi, Concettina La Motta, Giusy Elia, Francesca Ragusa, Ilaria Ruffilli, Armando Patrizio, Enke Baldini, Salvatore Ulisse, Alessandro Antonelli
Expert Review of Precision Medicine and Drug Development.2019; 4(1): 37. CrossRef Epigenetic modifications in poorly differentiated and anaplastic thyroid cancer
Thanyawat Sasanakietkul, Timothy D. Murtha, Mahsa Javid, Reju Korah, Tobias Carling
Molecular and Cellular Endocrinology.2018; 469: 23. CrossRef Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies
Eleonora Molinaro, Cristina Romei, Agnese Biagini, Elena Sabini, Laura Agate, Salvatore Mazzeo, Gabriele Materazzi, Stefano Sellari-Franceschini, Alessandro Ribechini, Liborio Torregrossa, Fulvio Basolo, Paolo Vitti, Rossella Elisei
Nature Reviews Endocrinology.2017; 13(11): 644. CrossRef c‐Met‐mediated reactivation of PI3K/AKT signaling contributes to insensitivity of BRAF(V600E) mutant thyroid cancer to BRAF inhibition
Hyung Kwon Byeon, Hwi Jung Na, Yeon Ju Yang, Hyeong Ju Kwon, Jae Won Chang, Myung Jin Ban, Won Shik Kim, Dong Yeob Shin, Eun Jig Lee, Yoon Woo Koh, Joo‐Heon Yoon, Eun Chang Choi
Molecular Carcinogenesis.2016; 55(11): 1678. CrossRef Anaplastic thyroid cancer
Rohit Ranganath, Manish A. Shah, Ashok R. Shah
Current Opinion in Endocrinology, Diabetes & Obesity.2015; 22(5): 387. CrossRef Orthotopic mouse models for the preclinical and translational study of targeted therapies against metastatic human thyroid carcinoma with BRAFV600E or wild-type BRAF
Z A Antonello, C Nucera
Oncogene.2014; 33(47): 5397. CrossRef Update on Anaplastic Thyroid Carcinoma: Morphological, Molecular, and Genetic Features of the Most Aggressive Thyroid Cancer
Moira Ragazzi, Alessia Ciarrocchi, Valentina Sancisi, Greta Gandolfi, Alessandra Bisagni, Simonetta Piana
International Journal of Endocrinology.2014; 2014: 1. CrossRef Genomically Driven Precision Medicine to Improve Outcomes in Anaplastic Thyroid Cancer
Nicole Pinto, Morgan Black, Krupal Patel, John Yoo, Joe S. Mymryk, John W. Barrett, Anthony C. Nichols
Journal of Oncology.2014; 2014: 1. CrossRef Anaplastic Thyroid Carcinoma: Current Treatments and Potential New Therapeutic Options with Emphasis on TfR1/CD71
Rosalba Parenti, Lucia Salvatorelli, Gaetano Magro
International Journal of Endocrinology.2014; 2014: 1. CrossRef Autophagy: A potential target for thyroid cancer therapy (Review)
HEQING YI, BIN LONG, XUEMEI YE, LIJUN ZHANG, XIAODONG LIU, CHUNYAN ZHANG
Molecular and Clinical Oncology.2014; 2(5): 661. CrossRef Update: The Status of Clinical Trials With Kinase Inhibitors in Thyroid Cancer
Samuel A. Wells, Massimo Santoro
The Journal of Clinical Endocrinology & Metabolism.2014; 99(5): 1543. CrossRef
|